GMDP is not alien molecules; our body meets them daily fighting off the attacks of “pathogenic” microbes by processing of “worn-out” useful bacteria bearing GMDP in their cell walls, i.e. potentially different analogues could become “molecule” of the drug – activator of innate immunity, upon clinical proof of its safety.